Seeking Alpha

jrusso9722

jrusso9722
Send Message
View jrusso9722's StockTalks BY TICKER:
  • jrusso9722
    $MELA has to show a strong 4Q 2012, or it's a long fall IMHO.
    12/27/12
    Reply
      • jrusso9722
        OSK diesel electric ProPulse, could launch sustained profits.. Army has 200,000 trucks.10-20% fuel saving,parts, maint. HUFE.
        11/20/12
        Reply
          • jrusso9722
            Long BONU. Bioneutral sterilant YGiene, kills pathogens, even Clost Dificiles. Sterilizes hosp equip .12 per share.H U G E potential.
            4/11/12
            Reply
              • jrusso9722
                There should be an information release, by MELA, in earl April, concluding first quarter, 2012, as well as more frequent news.
                3/15/12
                Reply
                  • jrusso9722
                    MELA up .31 cents and .04 additional in after hours trading. Decent volume, and, obviously up. I'm long MELA.
                    2/28/12
                    Reply
                      • jrusso9722
                        MELA on the brink of major gains. Feb 23, 2012 dermatologist study release is the prelude.
                        2/24/12
                        Reply
                          • jrusso9722
                            Mela Sciences has announced this morning, 11-2-11, that the FDA has approved MelaFind. MELA
                            11/2/11
                            Reply (1)
                            • tenax: huge story for MELA investors. here's the goods: http://yhoo.it/tGOL4O
                              11/2/11
                              • jrusso9722
                                BONU, so far, up 42% today 11-1-11. Ygiene kills germs better than any hospital cleaners. Risk is expensive-litigation. Long BONU.
                                11/1/11
                                Reply
                                  • jrusso9722
                                    Oshkosh OSK and it's union have reportedly settled on a contract
                                    10/7/11
                                    Reply (1)
                                    • Hillbilly Stock Star: OSK.......be careful!
                                      10/7/11
                                      • jrusso9722
                                        Congratulations to MELA with your FDA approval . Congratulations to victims of Melanoma,
                                        9/26/11
                                        Reply
                                          • jrusso9722
                                            Melafind has just won European Union approval. Wonderful news.MELA
                                            9/6/11
                                            Reply
                                              • jrusso9722
                                                Long MELA. 2nd half of year, looking for European approval. There's no way I'm getting out. MelaFind will save many lives here and abroad.
                                                4/13/11
                                                Reply
                                                  • jrusso9722
                                                    BONU- (long). Ygiene disenfectants better than bleach. Hospital Acquired Infections deadly. What facility would risk not using the best
                                                    3/23/11
                                                    Reply
                                                      • jrusso9722
                                                        BONU, Hospital infectins kill patients. a killer. Ygiene disenfectant works better than chlorine. Huge upside. Hosp will buy in quantity.
                                                        3/23/11
                                                        Reply
                                                          • jrusso9722
                                                            Jason, Hello. I wrote an instablog on MELA yesterday. 22% of stock is shorted. No Uptick Rule..MELA works with Dr.-client relationship. Long
                                                            12/3/10
                                                            Reply
                                                              • jrusso9722
                                                                MELA, The tide will turn. FDA will approve MelaFind, because it saves lives. Lawyer groups are all jumping to make a profit
                                                                12/2/10
                                                                Reply
                                                                  • jrusso9722
                                                                    25% of MELA is short. Cancer killer is the issue, not put, calls. MelaFind will be approved, or FDA will answer, as individuals.
                                                                    12/1/10
                                                                    Reply
                                                                      • jrusso9722
                                                                        MELA -Every Dr. will appreciate MelaFind. Every patient will too!! Shorts, Puts, all disgusting. The subject is preserving LIFE!!
                                                                        12/1/10
                                                                        Reply
                                                                          • jrusso9722
                                                                            OSK, ProPulse, TerraMax. 2 tech's to revolutionize wheel vehicles Diesel-Elect power. 200,000 truck mkt. huge.20% fuel save. Get in now.
                                                                            11/27/10
                                                                            Reply
                                                                              • jrusso9722
                                                                                Dr.images a mole with MELA, he/she is "biasing" decision on knowledge, does not image all moles. FDA "reports" make no sense, thus far
                                                                                11/17/10
                                                                                Reply